Allegheny Cancer Center at Allegheny General Hospital
Pittsburgh, Pennsylvania, United States
Cancer treatment center in Pittsburgh, Pennsylvania
320 E North Ave, Pittsburgh, PA 15212
About Allegheny Cancer Center at Allegheny General Hospital
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Allegheny Cancer Center at Allegheny General Hospital
During the past decade, Allegheny Cancer Center at Allegheny General Hospital conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 32 clinical trials were completed, i.e. on
average, 213.3% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 11 clinical trials were completed. i.e. 366.7%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer
1999-01-04
2007-03-31
Completed
350
Surgery With or Without Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal Cancer
2000-09-01
Unknown status
Cisplatin Plus Gemcitabine With or Without Paclitaxel in Treating Patients With Stage IV Urinary Tract Cancer
2001-05-01
Completed
608
A Study of Two Different Doses of ABT-378/Ritonavir in HIV-Infected Patients Who Have Taken Protease Inhibitors and Non-Nucleoside Reverse Transcriptase Inhibitors
2000-09-01
Completed
36
Surgery With or Without Radiation Therapy and Chemotherapy in Treating Patients With Esophageal Cancer
2002-05-01
2010-09-01
Completed
195
Hormone Therapy With or Without Docetaxel And Estramustine in Treating Patients With Prostate Cancer That is Locally Advanced or At High Risk of Relapse
2002-11-14
2022-12-31
Completed
413
Dual Boosted - Protease Inhibitor (PI) Pharmacokinetics (PK) Trial (Tipranavir / Ritonavir) in Highly Treatment-experienced HIV-1 Infected Patients
2003-01-01
Completed
328
A Safety and Efficacy Trial Evaluating the Use of Fondaparinux in Percutaneous Coronary Intervention (PCI)(63133)(WITHDRAWN)
2003-04-01
Withdrawn
300
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Allegheny Cancer Center at Allegheny General Hospital" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 17 trials, followed by "NSABP Foundation Inc" with 12 trials
sponsored, "Radiation Therapy Oncology Group" with 11 trials sponsored, "Hoffmann-La Roche" with 8 trials sponsored and "SWOG Cancer Research Network"
with 8 trials sponsored. Other sponsors include 17 different institutions and
companies that sponsored additional 23 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Allegheny Cancer Center at Allegheny General Hospital"
#1 collaborator was "National Cancer Institute (NCI)" with 47 trials as a collaborator, "Cancer and Leukemia Group B" with 7 trials as a collaborator, "North Central Cancer Treatment Group" with 6 trials as a collaborator, "Eastern Cooperative Oncology Group" with 5 trials as a collaborator and "SWOG Cancer Research Network" with 5 trials as a collaborator. Other collaborators include 21 different institutions and companies that were
collaborators in the rest 25 trials.
Clinical Trials Conditions at Allegheny Cancer Center at Allegheny General Hospital
According to Clinical.Site data, the most researched conditions in "Allegheny Cancer Center at Allegheny General Hospital" are
"Breast Cancer" (15 trials), "Lung Cancer" (9 trials), "Colorectal Cancer" (8 trials), "Brain and Central Nervous System Tumors" (3 trials) and "Non-Small Cell Lung Cancer" (3 trials). Many other conditions were trialed in "Allegheny Cancer Center at Allegheny General Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Allegheny Cancer Center at Allegheny General Hospital
Most popular intervention types in "Allegheny Cancer Center at Allegheny General Hospital" are "Drug" (57 trials), "Biological" (18 trials), "Radiation" (18 trials), "Procedure" (16 trials) and "Other" (14 trials). Other intervention types were less common.
The name of intervention was led by "radiation therapy" (10 trials), "fluorouracil" (8 trials), "Paclitaxel" (7 trials), "bevacizumab" (7 trials) and "cisplatin" (7 trials). Other intervention names were less common.
Clinical Trials Genders at Allegheny Cancer Center at Allegheny General Hospital
The vast majority of trials in "Allegheny Cancer Center at Allegheny General Hospital" are
57 trials for "All" genders, 12 trials for "Female" genders and 5 trials for "Male" genders.
Clinical Trials Status at Allegheny Cancer Center at Allegheny General Hospital
Currently, there are NaN active trials in "Allegheny Cancer Center at Allegheny General Hospital".
undefined are not yet recruiting,
5 are recruiting,
9 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 44 completed trials in Allegheny Cancer Center at Allegheny General Hospital,
undefined suspended trials,
and 12 terminated clinical trials to date.
Out of the total trials that were conducted in Allegheny Cancer Center at Allegheny General Hospital, 1 "Phase 1"
clinical trials were conducted, 18 "Phase 2" clinical
trials and 43 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 4 trials that are defined as “Not Applicable".